跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AG-LOSARTAN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AG-LOSARTAN
Authorized
STANDARD
AG-LOSARTAN
angita pharma inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
ad8b4a19930c803e
Company
angita pharma inc.
Type
Standard
Approval Details
Approval Id
ad8b4a19930c803e
Drug Approval Canada Name
AG-LOSARTAN
Product Name
AG-LOSARTAN
Status
Dormant
Status Date
2020-07-27
Original Market Date
2018-06-27
Din
02441209
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:32.08
Atc Original
C09CA01 LOSARTAN
Atc Name
c 09 ca 01
Aig Number
0127971003
Company Name
angita pharma inc.
Company Address
1310 Rue Nobel, Boucherville, Quebec, Canada, J4B 5H3
Active Ingredients
LOSARTAN POTASSIUM
50 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
ad8b4a19930c803e
Type
Standard
Back to Health Canada Approvals